State Street Health Care Select Sector SPDR ETF
The Nasdaq fell over 1% as AI-related stocks declined. RBC Capital Markets shifted sector allocations, upgrading health care and downgrading technology. Semtech (SMTC) saw mixed analyst actions, Klaviyo (KVYO) was downgraded, and Manhattan Associates (MANH) received split views. The S&P 500 is down 1.13% today and 2.02% this week, trading at 7,656.89.
AI stocks faced volatility, prompting capital rotation into pharmaceuticals. Eli Lilly (LLY) and AbbVie (ABBV) neared record highs, with LLY at $1,251.61 and ABBV at $283.40. Healthcare ETF XLV hit $177.19. LLY's gains were driven by its GLP-1 dominance and M&A activity, while ABBV's rally followed positive Skyrizi data. Other large-cap pharma stocks also rose, but biotech ETF XBI declined 2.8% over a month.
The article compares healthcare ETFs XLV (State Street Health Care Select Sector SPDR) and FHLC (Fidelity MSCI Health Care Index). XLV holds about 60 S&P 500 healthcare stocks, with over 25% concentrated in Eli Lilly and Johnson & Johnson, making results dependent on those firms. FHLC holds 300+ stocks, including mid/small caps, offering broader diversification but higher volatility, according to the article.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning XLV (State Street Health Care Select Sector SPDR ETF). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Relative bid versus the broader market as flows rotate toward health care on valuation and earnings-revision support.
The ETF is likely to keep rising as defensive capital stays in health care.
The article compares healthcare ETFs XLV (State Street Health Care Select Sector SPDR) and FHLC (Fidelity MSCI Health Care Index). XLV holds about 60 S&P 500 healthcare stocks, with over 25% concentrated in Eli Lilly and Johnson & Johnson, making results dependent on those firms. FHLC holds 300+ stocks, including mid/small caps, offering broader diversification but higher volatility, according to the article.
AlphAI scores every news story that mentions XLV with an AI model for sentiment and relevance, and aggregates insider trades from State Street Health Care Select Sector SPDR ETF's SEC EDGAR Form 4 filings. Figures refresh continuously.
The Nasdaq fell over 1% as AI-related stocks declined. RBC Capital Markets shifted sector allocations, upgrading health care and downgrading technology. Semtech (SMTC) saw mixed analyst actions, Klaviyo (KVYO) was downgraded, and Manhattan Associates (MANH) received split views. The S&P 500 is down 1.13% today and 2.02% this week, trading at 7,656.89.
7 min readAI stocks faced volatility, prompting capital rotation into pharmaceuticals. Eli Lilly (LLY) and AbbVie (ABBV) neared record highs, with LLY at $1,251.61 and ABBV at $283.40. Healthcare ETF XLV hit $177.19. LLY's gains were driven by its GLP-1 dominance and M&A activity, while ABBV's rally followed positive Skyrizi data. Other large-cap pharma stocks also rose, but biotech ETF XBI declined 2.8% over a month.
3 min readThe article compares healthcare ETFs XLV (State Street Health Care Select Sector SPDR) and FHLC (Fidelity MSCI Health Care Index). XLV holds about 60 S&P 500 healthcare stocks, with over 25% concentrated in Eli Lilly and Johnson & Johnson, making results dependent on those firms. FHLC holds 300+ stocks, including mid/small caps, offering broader diversification but higher volatility, according to the article.
3 min read